Early trial results in The Lancet show the cholesterol-lowering pills slow brain shrinkage in people with MS.
The University College London (UCL) scientists say large trials can now begin.
These will check whether statins benefit MS patients by slowing progression of the disease and easing their symptoms.
The University College London (UCL) scientists say large trials can now begin.
These will check whether statins benefit MS patients by slowing progression of the disease and easing their symptoms.
No comments:
Post a Comment